Biocardia Inc (BCDA)

Biocardia Inc (BCDA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $15.7M; returns 1 day -0.8%, 1 week +0.1%, 1 year -34.0%.

BioCardia, Inc. is a clinical-stage regenerative medicine company focused on developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its primary financial engine is capital raised through equity financing and non-dilutive funding, rather than commercial product sales, as it is pre-commercial with nominal current revenue (reported $0 revenue in Q3 2025).

Groups BCDA belongs to

• Biotechnology
• Regenerative Medicine
• Clinical Stage
• Clinical Stage Biotech
• Cardiovascular Therapies
• Autologous Cell Therapy
• Healthcare
• Biopharmaceutical
• Minimally Invasive Surgery
• Medical Devices
• Life Sciences
• Healthcare Technology

BCDA financial model: income statement, cash flow and balance sheet